Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01004861
Title Safety Study of PLX108-01 in Patients With Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Plexxikon
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Scottsdale Arizona 85258 United States Details
UCLA Los Angeles California 90404 United States Details
Rocky Mountain Cancer Centers Denver Colorado 80218 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 United States Details
Memorial Sloan-Kettering Cancer Center (MSKCC) New York New York 10065 United States Details
Pennsylvania Oncology Hematology Associates Philadelphia Pennsylvania 19106 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
Vanderbilt-Ingram Medical Center Nashville Tennessee 37232 United States Details
Texas Oncology, PA (North) Dallas Texas 75246 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
Evergreen Hematology & Oncology Spokane Washington 99218 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field